Brain cell signaling abnormalities are detected in blood in a murine model of Fragile X syndrome and corrected by Sigma‐1 receptor agonist Blarcamesine
Year: 2022
Type: article
DOI: 10.1002/ajmg.a.62853
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
Funder: FRAXA Research Foundation
OpenAlex ID: W4281736117
